Latex agglutination determination of IgG in neonatals and in colostrum
AssigneeMiles Laboratories, Inc.
InventorErnest C. Adams
Life of this patent
Estimating the term…
Abstract
A method for determining the amount of IgG present in a neonatal foal or calf or in the colostrum of a dam or cow. The method involves contacting a body fluid sample with biologically inert latex particles, measuring the amount of agglutination which occurs, and determining the amount of IgG present. The latex particles are diluted to a final concentration of from about 0.25 to 2.0 percent (w/v) at a pH of from about 7.5 to 9.0 with a buffer. The body fluid is diluted to a range of from 0.01:5 parts to 0.01:2160 parts, v/v basis, at a pH of from about 7.5 to 9.0.
Claims6
A method for determining the amount of IgG present in a neonatal calf or foal or in the colostrum of a cow or dam, which comprises the steps of contacting a body fluid sample from said neonatal or said colostrum with biologically inert latex particles, measuring the amount of agglutination which occurs and determining therefrom the amount of IgG present in said sample, wherein said latex particles, having a particle size from 0.109 to 0.81 microns are diluted with a buffer to a final concentration of from 0.25 to 2.0 percent, weight/volume basis at a pH of from about 7.5 to 9.0, and wherein said body fluid sample is diluted with a buffer to a range of from 0.01:5 parts to 0.01:2160 parts, v/v basis, at a pH of from about 7.5 to 9.0.
Dependencies are inferred from the claim text.